XML 28 R12.htm IDEA: XBRL DOCUMENT

Composition of Certain Consolidated Financial Statement Items

12 Months Ended

Dec. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Composition of Certain Consolidated Financial Statement Items

Inventory (in thousands):


	December 31,
	2023		2022

Raw materials	$	16,737	$	12,417
Work-in-process	1,142		1,738
Finished goods	21,877		14,388
Total inventory	$	39,756	$	28,543

Property and Equipment, Net (in thousands):


	December 31,
	2023		2022

Laboratory, manufacturing and computer equipment, and furniture and fixtures	$	15,610	$	3,260
Rental equipment	897		1,313
Leasehold improvements	12,362		4,941
Evaluation units	—		2,475
Construction in progress	3,548		5,671
Total property and equipment	32,417		17,660
Less: accumulated depreciation and amortization	(3,669)		(9,004)
Total property and equipment, net	$	28,748	$	8,656

Other Current Liabilities (in thousands):


	December 31,
	2023		2022

Accrued purchases	106		2,006
Professional services	1,558		1,739
Sales tax	1,725		829
Interest	333		532
Travel expenses	519		429
Asset retirement obligation	232		200
Clinical trial expenses	392		175
Other	1,453		1,558
Total other current liabilities	$	6,318	$	7,468

As of December 31, 2022, other non-current liabilities consisted of an asset retirement obligation for the facility lease which was terminated as of December 31, 2023.

Interest and Other Income (Expense), net (in thousands):


	Year Ended December 31,
	2023		2022		2021

Interest income	$	7,551	$	2,497	$	76
Decrease in fair value of preferred stock warrants	—		—		64
Change in fair value of loan facility derivative liability	(107)		(283)		135
Other	(176)		(203)		(154)
Total interest and other income, net	$	7,268	$	2,011	$	121